Skip to main content

Published locations for First report from NeoTRIPaPDL1: No pCR benefit with atezolizumab in TNBC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. First report from NeoTRIPaPDL1: No pCR benefit with atezolizumab in TNBC

User login

  • Reset your password
  • /content/first-report-neotripapdl1-no-pcr-benefit-atezolizumab-tnbc
  • /oncologypractice/article/214408/breast-cancer/first-report-neotripapdl1-no-pcr-benefit-atezolizumab
  • /hematology-oncology/article/214408/breast-cancer/first-report-neotripapdl1-no-pcr-benefit
  • /emergencymedicine/article/214408/breast-cancer/first-report-neotripapdl1-no-pcr-benefit-atezolizumab
  • /breast-cancer-icymi/article/214408/breast-cancer/first-report-neotripapdl1-no-pcr-benefit